跳至主要内容
临床试验/NCT04751448
NCT04751448招募中不适用

COLON MD: Colon Cancer Longitudinal Study of the Microbial Metabolites and Dietary Factors That Influence Response to Treatment

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
11
试验地点
1
主要终点
Microbiome-Based Prediction of Chemotherapy-induced Diarrhea in Colon Cancer

研究概览

简要总结

The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.

详细描述

In this longitudinal observational study patients will supply samples of their gut microbiome prior to scheduled colonoscopy or surgery along with dietary intake and blood samples; the relative abundance of microbes from those samples along with dietary data will be used to predict the presence or absence and severity of chemotherapy-induced diarrhea. Microbiome and diet based predictions from blinded samples will be combined to map the diet-microbiome changes during treatment to the changes in immune markers and risk of chemotherapy-induced diarrhea.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Colon cancer diagnosis
  • Age >18 and < or equal to
  • Ability to perform informed consent
  • FOLFOX treatment expected

排除标准

  • Not Pregnant
  • Does not have Lynch syndrome or FAP diagnosis.
  • Inability to perform inform consent
  • inability to comply with follow up program
  • history of prior colon cancer diagnosis
  • previous treatment with antibiotics in the last month.
  • previous bowel resection.

研究组 & 干预措施

Observational

All patients going on study will be put in the observational grouping for blood and tissue collection with option for stool collection.

结局指标

主要结局

Microbiome-Based Prediction of Chemotherapy-induced Diarrhea in Colon Cancer

时间窗: 3 years

Microbiome analysis from at least 112 blinded samples will be conducted from fecal samples to determine sensitivity, specificity and accuracy (reported as percentage) of a microbiome-based predictor of chemotherapy-induced diarrhea in colon cancer.

次要结局

  • Dietary-Based Prediction of Chemotherapy-induced Diarrhea in Colon Cancer(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

COLON-MD: Colon Cancer Longitudinal Study | 临床试验